Pharmacology Research Institute

Pharmacology Research Institute (PRI) is a clinical research organization (CRO) and site network that specializes in conducting Phase 2, 3, and 4 clinical trials for the pharmaceutical and biotechnology industries. Founded in 1975, the institute operates several research centers in Southern California, focusing primarily on neuropsychiatric and neurological disorders. PRI provides comprehensive clinical trial services, including patient recruitment, study coordination, and regulatory compliance, with a strong emphasis on Central Nervous System (CNS) research. The organization has participated in hundreds of clinical trials, contributing significantly to the development and FDA approval of various medications for conditions like Alzheimer's and depression.